(74 days)
Not Found
No
The document describes a laser system for ophthalmic procedures and a diagnostic slit lamp. There is no mention of AI or ML in the intended use, device description, or performance studies summary. The focus is on the laser technology and its application.
Yes
The device is described as an "ophthalmic surgical laser system intended for use in the treatment of ocular pathology." It performs procedures such as posterior capsulotomy, pupillary membranectomy, iridotomy/iridectomy, and selective laser trabeculoplasty, which are all therapeutic interventions.
Yes
The "Intended Use / Indications for Use" section explicitly states that the "Selecta 1064, Selecta SLT and Selecta Duo Ophthalmic Lasers are also intended for use as a diagnostic slit lamp, specifically, An AC-powered slit lamp biomicroscope intended for use in eye examination of the anterior segment... It is used to aid in the diagnosis of diseases or trauma which affects the structural properties of the anterior segment."
No
The device description clearly states it is a "fully integrated flash lamp pumped, solid state, Nd: YAG ophthalmic surgical laser system" and describes various hardware components like lasers, optics, and delivery systems. While it includes software for control, it is fundamentally a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The primary intended use of the Selecta devices is for photodisruption and selective laser trabeculoplasty of ocular tissue using laser energy. This is a therapeutic intervention, not a diagnostic test performed on samples taken from the body.
- Diagnostic Function: While the devices are also intended for use as a diagnostic slit lamp for eye examination, this is a direct examination of the patient's eye using light, not an in vitro test on a biological sample. The slit lamp aids in the diagnosis of diseases or trauma by allowing the ophthalmologist to visually inspect the anterior segment.
- Device Description: The device description focuses on the laser technology and its application for treating ocular conditions.
- Lack of IVD Characteristics: There is no mention of the device being used to examine or analyze biological samples (like blood, urine, tissue, etc.) outside of the body. The device interacts directly with the patient's eye.
In summary, the Selecta Ophthalmic Lasers are therapeutic devices with an integrated diagnostic function (slit lamp) that involves direct examination of the patient, not in vitro testing of biological samples.
N/A
Intended Use / Indications for Use
Selecta 1064: photodisruption of ocular tissue using light energy emitted by a Nd:YAG laser, including discission of the posterior capsule of the eye (posterior capsulotomy), and discission of pupillary membranes (pupillary membranectomy) in aphakic and pseudophakic patients, and iridotomy/iridectomy
Selecta SLT: selective laser trabeculoplasty
Selecta Duo: photodisruption of ocular tissue using light energy emitted by a Nd:YAG laser, including discission of the posterior capsule of the eye (posterior capsulotomy), and discission of pupillary membranes (pupillary membranectomy) in aphakic and pseudophakic patients, and iridotomy/iridectomy; and selective laser trabeculoplasty
The Selecta 1064, Selecta SLT and Selecta Duo Ophthalmic Lasers are also intended for use as a diagnostic slit lamp, specifically, An AC-powered slit lamp biomicroscope intended for use in eye examination of the anterior segment, from the cornea epithelium to the posterior capsule. It is used to aid in the diagnosis of diseases or trauma which affects the structural properties of the anterior segment.
LaserLink S: laser delivery system for use by an ophthalmologist in the treatment of ocular tissue; laser delivery system indicated for use for a variety of ophthalmic uses, including the indications specified in the laser operator manual. Refer to the laser operator manual, Indications for Use section.
Product codes (comma separated list FDA assigned to the subject device)
HQF, GEX
Device Description
The Lumenis Selecta is a fully integrated flash lamp pumped, solid state, Nd: YAG ophthalmic surgical laser system intended for use in the treatment of ocular pathology and for use as a diagnostic slit lamp.
The Family of Selecta Ophthalmic Lasers, Delivery Device and Accessories consists of the following models:
-
I) Selecta 1064° a Nd: YAG laser providing Q-switched laser pulses at a wavelength of 1064nm for use in photodisruption of ocular tissue (posterior capsulotomy, pupillary membranectomy, iridotomy). The 1064nm treatment beam delivers a 4 nsec, 0.3-10mJ adjustable and selectable single, double or triple pulse of energy. It is conditioned through beam shaping optics to generate a photodisruption micro pulse of plasma at a precision adjustable location relative to the visual focal plane (located at slit lamp center of rotation) and along the slit lamp objective lens axis. A twin aiming beam is also focused by the slit lamp objective to a converging 20um spot located at the focal point of the lens. The focal point of photodisruption is adjustable 0-350um in the posterior direction by the physician relative to this convergence of the twin aiming beams.
-
- Selecta SLT® -- a Nd: YAG laser providing Q-switched frequency doubled pulses at a wavelength of 532nm for use in selective laser trabeculoplasty. The treatment beam delivers a 4nsec, 0.1-2mJ adjustable single pulse of energy. The aiming and treatment beams are coaxial with each other and focused by the slit lamp objective to a 400um spot at the focal point of the lens.
-
- Selecta Duo a Nd:YAG laser providing Q-switched laser pulses at a wavelength of 1064 nanometers for use in photodisruption or Q-switched frequency doubled pulses at a wavelength of 532nm for use in selective laser trabeculoplasty, depending upon the mode selected. The Selecta Duo contains two aiming beam modules that produce a single beam for the 532nm mode and a dual beam for the 1064nm mode, respectively.
For each Selecta model, the physician controls delivery of laser energy from the Selecta remote control display unit and activates the treatment laser beam with a footswitch or joystick pushbutton. In addition, a laser slit lamp delivery adaptor, the LaserLink S, may be coupled to each of the above Selecta models and connected to a currently cleared Lumenis 532nm photocoagulator to allow the physician to use the Selecta slit lamp to deliver 532nm continuous wave laser energy for photocoagulation.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Ocular tissue, eye, anterior segment (cornea epithelium to posterior capsule)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Physician, ophthalmologist
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
System and software hazard analysis information, software verification and validation information, and clinical literature were submitted in conjunction with this Premarket Notification submission. The determination of substantial equivalence was based upon the comparison of the technical characteristics between the Family of Selecta Ophthalmic Laser Systems, Delivery Device and Accessories and the predicate laser systems and the evaluation of the performance data.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K021550, K973470, K004006, K022181
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 886.4390 Ophthalmic laser.
(a)
Identification. An ophthalmic laser is an AC-powered device intended to coagulate or cut tissue of the eye, orbit, or surrounding skin by a laser beam.(b)
Classification. Class II.
0
K 051944
SEP 3 0 2005 Attachment 10 510(k) Summary Statement
I. General Information
Submitter:
Lumenis, Inc. 2400 Condensa Street Santa Clara, California, U. S. A. 95051-0901
Contact Persons:
Karen L. Baker
Summary Preparation Date: July 15, 2005
II. Names
Device Names:
Family of Selecta Ophthalmic Laser Systems, Delivery Device and Accessories Selecta 1064 Ophthalmic Laser System Selecta SLT Ophthalmic Laser System Selecta Duo Ophthalmic Laser System LaserLink S
Primary Classification Name: 79, General and Plastic Surgery Panel
GEX, Laser powered surgical instrument
III. Predicate Devices
- Lumenis Selecta Duet (K021550) ●
- Coherent Popeye Ophthalmic Laser and Coherent Popeye Ophthalmic Laser in . Combination with the Coherent Ultima 2000 Laser Photocoagulator Coherent Popeye Nd: YAG Ophthalmic Laser Systems (K973470)
- t Selecta 7000 Frequency Doubled Q-Switched Nd: Y AG Ophthalmic Laser (K004006)
- LaserLink Z-1000 (K022181) .
IV. Product Description
The Lumenis Selecta is a fully integrated flash lamp pumped, solid state, Nd: YAG ophthalmic surgical laser system intended for use in the treatment of ocular pathology and for use as a diagnostic slit lamp.
The Family of Selecta Ophthalmic Lasers, Delivery Device and Accessories consists of the following models:
- I) Selecta 1064° a Nd: YAG laser providing Q-switched laser pulses at a wavelength of 1064nm for use in photodisruption of ocular tissue (posterior capsulotomy, pupillary membranectomy, iridotomy). The 1064nm treatment beam delivers a 4 nsec, 0.3-10mJ adjustable and selectable single, double or triple pulse of energy. It is
1
conditioned through beam shaping optics to generate a photodisruption micro pulse of plasma at a precision adjustable location relative to the visual focal plane (located at slit lamp center of rotation) and along the slit lamp objective lens axis. A twin aiming beam is also focused by the slit lamp objective to a converging 20um spot located at the focal point of the lens. The focal point of photodisruption is adjustable 0-350um in the posterior direction by the physician relative to this convergence of the twin aiming beams.
-
- Selecta SLT® -- a Nd: YAG laser providing Q-switched frequency doubled pulses at a wavelength of 532nm for use in selective laser trabeculoplasty. The treatment beam delivers a 4nsec, 0.1-2mJ adjustable single pulse of energy. The aiming and treatment beams are coaxial with each other and focused by the slit lamp objective to a 400um spot at the focal point of the lens.
-
- Selecta Duo a Nd:YAG laser providing Q-switched laser pulses at a wavelength of 1064 nanometers for use in photodisruption or Q-switched frequency doubled pulses at a wavelength of 532nm for use in selective laser trabeculoplasty, depending upon the mode selected. The Selecta Duo contains two aiming beam modules that produce a single beam for the 532nm mode and a dual beam for the 1064nm mode, respectively.
For each Selecta model, the physician controls delivery of laser energy from the Selecta remote control display unit and activates the treatment laser beam with a footswitch or joystick pushbutton. In addition, a laser slit lamp delivery adaptor, the LaserLink S, may be coupled to each of the above Selecta models and connected to a currently cleared Lumenis 532nm photocoagulator to allow the physician to use the Selecta slit lamp to deliver 532nm continuous wave laser energy for photocoagulation.
V. Indications for Use
photodisruption of ocular tissue using light energy emitted by a Nd: Y AG Selecta 1064: laser, including discission of the posterior capsule of the eye (posterior capsulotomy), and discission of pupillary membranes (pupillary membranectomy) in aphakic and pseudophakic patients, and iridotomy
selective laser trabeculoplasty Selecta SLT:
- photodisruption of ocular tissue using light energy emitted by a Nd: YAG Selecta Duo: laser, including discission of the posterior capsule of the eye (posterior capsulotomy), and discission of pupillary membranes (pupillary membranectomy) in aphakic and pseudophakic patients, and iridotomy; and
selective laser trabeculoplasty
The Selecta 1064, Selecta SLT and Selecta Duo Ophthalmic Lasers are also intended for use as a diagnostic slit lamp, specifically,
An AC-powered slit lamp biomicroscope intended for use in eye examination of the anterior segment, from the cornea epithelium to the posterior capsule. It is used to aid in
2
the diagnosis of diseases or trauma which affects the structural properties of the anterior segment
- LaserLink S: laser delivery system for use by an ophthalmologist in the treatment of ocular tissue;
laser delivery system indicated for use for a variety of ophthalmic uses, including the indications specified in the laser operator manual. Refer to the laser operator manual, Indications for Use section.
VI. Rationale for Substantial Equivalence
The Family of Selecta Ophthalmic Laser Systems, Delivery Device and Accessories have the same intended uses and indications for use as the predicate devices, and havens imilar technological characteristics as the predicate devices - treatment wavelength, laser media, mode of operation, energy output, pulse duration, pulse settings, spot sizes, aiming beam, cooling system, laser energy delivery control (footswitch/ handswitch), and delivery system - as the predicate devices, and therefore are substantially equivalent to the predicate devices referenced in Section III.
Performance Data VII.
System and software hazard analysis information, software verification and validation information, and clinical literature were submitted in conjunction with this Premarket Notification submission. The determination of substantial equivalence was based uppor the comparison of the technical characteristics between the Family of Selecta Ophthalmic Laser Systems, Delivery Device and Accessories and the predicate laser systems and the evaluation of the performance data.
VIII. Conclusion
The Family of Selecta Ophthalmic Laser Systems, Delivery Device and Accessories are substantially equivalent to similar predicate laser devices, delivery systems and accessories. The Family of Selecta Ophthalmic Laser Systems, Delivery Device and Accessories share the same intended use, indications for use, and technological characteristics as the predicate laser systems.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles a human figure with three arms or lines extending upwards, representing health, services, and the human aspect of the department's mission.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP 3 0 2005
Ms. Karen L. Baker Manager, Regulatory Affairs Lumenis. Inc. 2400 Condensa Street Santa Clara, California 95051
Re: K051944
Trade/Device Name: Family of Selecta Ophthalmic Laser Systems (Selecta SLT, Selecta 1064, and Selecta Duo) and Delivery Device (LaserLink S) and Accessories Regulation Number: 21 CFR 886.4390 Regulation Name: Ophthalmic laser Regulatory Class: II Product Code: HQF, GEX Dated: July 15, 2005 Received: July 18, 2005
Dear Ms. Baker:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
4
Page 2- Ms. Karen L. Baker
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Mark A. Millman
Mark N. Melkerson Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Attachment 2 Indications for Use Statement as Requested by FDA
510(K) Number (if Known):
K 051944
Device Name: Family of Selecta Ophthalmic Laser Systems (Selecta SLT, Selecta 1064, and Selecta Duo) and Delivery Device (LaserLink S) and Accessories
Indications for Use:
photodisruption of ocular tissue using light energy emitted by a Nd:YAG Selecta 1064: laser, including discission of the posterior capsule of the eye (posterior capsulotomy), and discission of pupillary membranes (pupillary membranectomy) in aphakic and pseudophakic patients, and iridotomy/iridectomy
selective laser trabeculoplasty Selecta SLT:
- photodisruption of ocular tissue using light energy emitted by a Nd: Y AG Selecta Duo: laser, including discission of the posterior capsule of the eye (posterior capsulotomy), and discission of pupillary membranes (pupillary membranectomy) in aphakic and pseudophakic patients, and iridotomy/iridectomy; and
selective laser trabeculoplasty
The Selecta 1064, Selecta SLT and Selecta Duo Ophthalmic Lasers are also intended for use as a diagnostic slit lamp, specifically,
An AC-powered slit lamp biomicroscope intended for use in eye examination of the anterior segment, from the cornea epithelium to the posterior capsule. It is used to aid in the diagnosis of diseases or trauma which affects the structural properties of the anterior segment.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON AND THER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) |
|---|
| Division of General, Restorative, and Neurological Devices |
| 510(k) Number | K051944 |
|---|---|
| --------------- | --------- |
| Prescription Use: | ✓ (Per 21 CFR 801.109)
Optional Format 1-2-96 | OR | Over-The-Counter Use: ________ |
| ------------------- | ---------------------------------------------------------------------------------------------------------------- | ---- | -------------------------------- |
|---|
6
Attachment 2, Continued Indications for Use Statement as Requested by FDA
510(K) Number (if Known):
Device Name: Family of Selecta Ophthalmic Laser Systems (Selecta SLT, Selecta 1064, and Selecta Duo) and Delivery Device (LaserLink S) and Accessories
Indications for Use:
LaserLink S: laser delivery system for use by an ophthalmologist in the treatment of ocular tissue;
laser delivery system indicated for use for a variety of ophthalmic uses, including the indications specified in the laser operator manual. Refer to the laser operator manual, Indications for Use section.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use:
(Per 21 CFR 801.109) OR Over-The-Counter Use: __
Optional Format 1-2-96
(Division Sign-Off)
Division of General, Restorative,
and Neurological Devices
510(k) Number __ K051944